You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nemolizumab

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Tempe, Lincoln (Nemolizumab)

Completed
  • Healthy Volunteers
  • Nemolizumab
  • Tempe, Arizona
  • +1 more
Dec 13, 2022

Systemic Sclerosis Trial in Tokyo (nemolizumab)

Recruiting
  • Systemic Sclerosis
  • nemolizumab
  • Tokyo, Japan
    The University of Tokyo Hospital
May 11, 2022

Atopic Dermatitis Trial in Bulgaria, United States (Nemolizumab, CYP 450 Substrates)

Recruiting
  • Atopic Dermatitis
  • Nemolizumab
  • CYP 450 Substrates
  • North Hollywood, California
  • +6 more
Nov 29, 2022

Prurigo Nodularis Trial in Austria, United States (Nemolizumab, Placebo)

Recruiting
  • Prurigo Nodularis
  • Nemolizumab
  • Placebo
  • Irvine, California
  • +4 more
Aug 12, 2022

Moderate-to-severe Atopic Dermatitis Trial (Nemolizumab, CD14152 )

Withdrawn
  • Moderate-to-severe Atopic Dermatitis
  • Nemolizumab
  • CD14152 placebo
  • (no location specified)
Jan 6, 2022

Moderate-to-Severe Atopic Dermatitis Trial in Worldwide (Nemolizumab)

Recruiting
  • Moderate-to-Severe Atopic Dermatitis
  • Nemolizumab
  • Fountain Valley, California
  • +30 more
Jul 20, 2022

Chronic Kidney Disease Associated Moderate to Severe Pruritus Trial in Worldwide (Nemolizumab, Placebo)

Recruiting
  • Chronic Kidney Disease Associated Moderate to Severe Pruritus
  • Nemolizumab
  • Placebo
  • Hoover, Alabama
  • +77 more
Dec 13, 2022

Moderate-to-Severe Atopic Dermatitis Trial in Worldwide (Placebo, Nemolizumab)

Active, not recruiting
  • Moderate-to-Severe Atopic Dermatitis
  • Placebo
  • Nemolizumab
  • Little Rock, Arkansas
  • +201 more
Aug 24, 2022

Atopic Dermatitis Trial in Worldwide (Nemolizumab, Placebo)

Completed
Has Results
  • Atopic Dermatitis
  • Nemolizumab
  • Placebo
  • Birmingham, Alabama
  • +66 more
Oct 3, 2019